Mortality in patients with behavioural and psychological symptoms of dementia: a registry-based study

被引:31
|
作者
Bransvik, Vanja [1 ]
Granvik, Eva [2 ]
Minthon, Lennart [1 ,2 ]
Nordstrom, Peter [3 ]
Nagga, Katarina [1 ,4 ,5 ]
机构
[1] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden
[2] Skane Univ Hosp, Memory Clin, Malmo, Sweden
[3] Umea Univ, Dept Community Med & Rehabil, Geriatr, Umea, Sweden
[4] Linkoping Univ, Dept Acute Internal Med & Geriatr, Linkoping, Sweden
[5] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
关键词
Behavioural and psychological symptoms of dementia; mortality; BPSD; Neuropsychiatric Inventory; nursing homes; registry-based study; NURSING-HOME RESIDENTS; NEUROPSYCHIATRIC SYMPTOMS; PSYCHIATRIC-SYMPTOMS; ALZHEIMERS-DISEASE; HIP-FRACTURES; RISK; PREVALENCE; COHORT; ANTIPSYCHOTICS; PREDICTORS;
D O I
10.1080/13607863.2020.1727848
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Behavioural and psychological symptoms of dementia (BPSD) are common in patients with dementia. In the elderly population, comorbidities frequently coexist with dementia and mortality in dementia is high. The aim of this study was to investigate the impact of BPSD on mortality in severe dementia. Methods: This study of 11,448 individuals was based on linked information from the Swedish BPSD registry, the National Patient Register and the Cause of Death register. BPSD was assessed with the Neuropsychiatric Inventory (NPI). Cox proportional hazards regressions were performed for survival analysis. To study different degrees of BPSD, data was categorized into groups: no (NPI, 0 points), mild (NPI, 1-3 points on >= 1 item), moderate (NPI, 4-8 points on >= 1 item) and severe (NPI, 9-12 points on >= 1 item) BPSD based on the highest score on any of the BPSD assessed (NPI items). Results: The presence of moderate or severe BPSD was associated with a stepwise increased risk of mortality (hazard ratio (HR), 1.31; 95% confidence interval (CI), 1.08-1.60 and HR 1.74; 95% CI 1.44-2.12, respectively) compared with individuals with no BPSD. In addition, there was an association between total NPI score and mortality (HR 1.01; 95% CI 1.007-1.010). The results remained significant after multivariable adjustment for age, sex, dementia diagnosis, medication, previous myocardial infarction, hip fracture and stroke. Conclusions: The results show a stepwise increase in mortality risk with increased BPSD, highlighting the importance of adequate management of BPSD to reduce mortality in dementia.
引用
下载
收藏
页码:1101 / 1109
页数:9
相关论文
共 50 条
  • [21] A retrospective study of the Behavioural and Psychological Symptoms of Dementia (BPSD) in patients admitted to a Specialist Dementia Care Unit
    Djekovic, Kate
    Clowes, Kim
    Spalding, Natasha
    Waite, Louise
    AUSTRALASIAN JOURNAL ON AGEING, 2022, 41 : 21 - 21
  • [22] Dementia increases mortality beyond effects of comorbid conditions: A national registry-based cohort study
    Taudorf, Laerke
    Norgaard, Ane
    Brodaty, Henry
    Laursen, Thomas Munk
    Waldemar, Gunhild
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (07) : 2174 - 2184
  • [23] Trends in Melanoma Mortality in Brazil: A Registry-Based Study
    Marta, Guilherme Nader
    Munhoz, Rodrigo Ramella
    Teixeira, Monica La Porte
    Waldvogel, Bernadette Cunha
    de Camargo, Veridiana Pires
    Feher, Olavo
    Sanches, Jose Antonio
    JCO GLOBAL ONCOLOGY, 2020, 6 : 1766 - 1771
  • [24] Mortality of congenital osteochondrodysplasias: A nationwide registry-based study
    Morales-Piga, Antonio
    Alonso-Ferreira, Veronica
    Villaverde-Hueso, Ana
    Posada de la Paz, Manuel
    Lopez-Abente, Gonzalo
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161A (07) : 1555 - 1560
  • [25] Prazosin for the management of behavioural and psychological symptoms of dementia
    Tampi, Rajesh R.
    Tampi, Deena J.
    Farheen, Syeda Arshiya
    Adnan, Mahwish
    Dasarathy, Dhweeja
    DRUGS IN CONTEXT, 2022, 11
  • [26] Light therapy for behavioural and psychological symptoms of dementia
    Skjerve, A
    Bjorvatn, B
    Holsten, F
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (06) : 516 - 522
  • [27] Yokukansan in the treatment of behavioural and psychological symptoms of dementia
    Matsuda, Y.
    Kishi, T.
    Shibayama, H.
    Iwata, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S541 - S541
  • [28] Clinical issues in the behavioural and psychological symptoms of dementia
    Luxenberg, JS
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 : S5 - S8
  • [29] Aripiprazole for treatment of behavioural psychological symptoms of dementia
    Hamuro, Atsushi
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (06): : 556 - 556
  • [30] The effectiveness of risperidone on behavioural and psychological symptoms of dementia
    Lee, C. H.
    Kim, Y. D.
    Kim, D. -Hee
    Kim, D. -Hong
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S554 - S554